During the past decade, Emel Taşvuran Horata conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Emel Taşvuran Horata" are "Arthroplasty Complications" (1 trials), "Cancer" (1 trials), "Cerebral Palsy" (1 trials), "Gait Disorders in Children" (1 trials) and "Musculoskeletal Injury" (1 trials). Many other conditions were trialed in "Emel Taşvuran Horata" in a lesser frequency.

Most popular intervention types in "Emel Taşvuran Horata" are "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dual tak gait assessment (motor+cognitive)" (1 trials), "Dual task gait assessment (motor+motor)" (1 trials), "Dual-task training" (1 trials), "EQ-5D-5L" (1 trials) and "Gait assessment (single)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emel Taşvuran Horata" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Emel Taşvuran Horata". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Emel Taşvuran Horata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emel Taşvuran Horata, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".